The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD

被引：3
|
作者：
Ferguson, Gary T. [1 ]
Pizzichini, Emilio [2 ]
Flezar, Matjaz [3 ]
Groenke, Lars [4 ]
Korducki, Lawrence [5 ]
机构：
[1] Inst Southeast Michigan, Pulm Res, Livonia, MI USA
[2] Univ Fed Santa Catarina, NUPAIVA Asthma Res Ctr, Florianopolis, SC, Brazil
[3] Klin Golnik, Univ Clin Resp & Allerg Dis, Golnik, Slovenia
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Med Affairs Dept, Ingelheim, Germany
[5] Boehringer Ingelheim Pharmaceut Inc, Dept Stat, Ridgefield, CT 06877 USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
COPD; -; management; Lung function testing; Spirometry;
D O I：
10.1183/13993003.congress-2015.PA2957
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2957
引用
收藏
页数：3
相关论文
共 50 条
  • [1] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    RESPIROLOGY, 2016, 21 : 129 - 129
  • [2] Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers
    McGarvey, Lorcan
    Buhl, Roland
    Korducki, Lawrence
    Amatto, Valeria C.
    Tetzlaff, Kay
    Bjermer, Leif
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [3] Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers
    Derom, Eric
    Korn, Stephanie
    Hamilton, Alan
    Amatto, Valeria C.
    Zhao, Yihua
    Maltais, Francois
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Initial Disease Severity
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD
    Muruganandan, Sanjeevan
    Jayaram, Lata
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1179 - 1189
  • [6] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Previous Usage Of Inhaled Corticosteroids
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [7] Pharmacokinetics and safety of tiotropium plus olodaterol 5 μg/5 μg fixed-dose combination in Chinese patients with COPD
    Wang, Zhenlei
    Tadayasu, Yusuke
    Hu, Na
    Shu, Shiqing
    Hu, Chao
    Luo, Zhu
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 63
  • [8] A BUDGET IMPACT MODEL FOR TIOTROPIUM/OLODATEROL VERSUS FIXED-DOSE COMBINATION TRIPLE THERAPY IN PATIENTS WITH COPD
    Palli, S. R.
    Clark, B.
    VALUE IN HEALTH, 2022, 25 (07) : S431 - S431
  • [9] Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
    Maltais, Francois
    Hamilton, Alan
    Voss, Florian
    Maleki-Yazdi, M. Reza
    ADVANCES IN THERAPY, 2019, 36 (04) : 962 - 968
  • [10] Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
    François Maltais
    Alan Hamilton
    Florian Voß
    M. Reza Maleki-Yazdi
    Advances in Therapy, 2019, 36 : 962 - 968
12345